WSP Global presses ahead with €5.4 billion Arcadis takeover bid

Canada's WSP Global on Thursday reconfirmed its plan to acquire Dutch engineering group Arcadis, preparing an offer memorandum for regulators by October 15 after two bids worth up to €5.4 billion were rejected.

"One can hardly argue that this is a friendly manoeuvre," said Kristof Samoy, an analyst at KBC Securities, who suspected the move was WSP's final attempt to force the Arcadis board to the negotiating table. "Only a very high proposal (€60 per share) stands a chance in our view."

Arcadis rejected an improved proposal of €51.5 per share in July, roughly 51 percent above the €34 level where the stock traded a day before Reuters reported the possible bid. The latest price would value Arcadis around €5.4 billion including debt, according to Reuters calculations. Stichting Lovinklaan, an employee foundation holding the largest stake of 19 percent, does not intend to support the takeover, Dutch daily FD reported.

WSP's options for pursuing Arcadis without board support appear limited by the Dutch corporate anti-takeover mechanism known as the poison pill, designed to thwart hostile acquisitions. With the board and its largest shareholder opposed, a successful deal likely hinges on a substantially higher offer — KBC's Samoy pegs the threshold near €60 per share.

The market has already begun pricing in the possibility of a richer bid. Arcadis shares rose more than 3 percent on Aug. 19 to around €44.06 on Euronext Amsterdam after the shareholder opposition became public, extending a year-to-date gain of 18.92 percent. The stock had fallen to €34 before the takeover attempt was announced, and its market value has partly recouped losses incurred in recent years.

Valuation gap widens the negotiating range

A forecast-based assessment set a fair value of €47.06 for Arcadis, implying roughly 11 percent upside from current levels and suggesting the shares may still trade below intrinsic value even after the rally. That gap helps explain why a 19 percent shareholder would view the current offer terms as insufficient relative to potential long-term value, and why the market's reaction to the resistance has been a price increase rather than a selloff.

WSP did not disclose a new offer price or the payment structure, and said the Arcadis boards had yet to engage with it. The Canadian firm, which trades on the Toronto Stock Exchange, plans to submit the offer memorandum to the Dutch financial watchdog for review and approval by October 15. A successful merger would create one of the largest global consulting and engineering firms, reshaping competitive dynamics in a sector that also includes peers such as AECOM and Jacobs.

For investors, the deal now turns on whether WSP is willing to raise its offer toward the €60-per-share level that KBC's Samoy says stands a chance, or whether the poison pill and shareholder opposition force it to walk away. If the board continues to refuse engagement, WSP's hostile path is constrained — but the October 15 filing deadline gives both sides a defined window to resolve the standoff.

This article is for informational purposes only and does not constitute investment advice.